CervoMed (CRVO) Misses Q2 EPS by 27c
Tweet
Share
E-mailCervoMed (NASDAQ: CRVO) reported Q2 EPS of ($0.27). Revenue for the quarter came in at $3.29 million.
For earnings history and earnings-related data on CervoMed (CRVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades FTC Solar Inc. (FTCI) to Buy
- UBS Upgrades Waste Connections Inc. (WCN) to Buy
- UBS Downgrades Anhui Jianghuai Automobile Group Co Ltd (600418:CH) to Sell
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
